Key result
Angiotensin-II induces melanoma cell proliferation and migration through direct binding and activation of the Angiotensin Converting Enzyme, triggering nuclear calcium signaling.
Absolute Event Rate: 11000% vs 1500%
p-value: p=<0.05
ACE acts as a direct receptor for Ang-II, mediating intracellular calcium signaling via PLCβ3 and regulating melanoma cell proliferation and migration.
BACKGROUND: The angiotensin-I converting enzyme (ACE) plays a central role in the renin-angiotensin system, acting by converting the hormone angiotensin-I to the active peptide angiotensin-II (Ang-II). More recently, ACE was shown to act as a receptor for Ang-II, and its expression level was demonstrated to be higher in melanoma cells compared to their normal counterparts. However, the function that ACE plays as an Ang-II receptor in melanoma cells has not been defined yet. AIM: Therefore, our aim was to examine the role of ACE in tumor cell proliferation and migration. RESULTS: We found that upon binding to ACE, Ang-II internalizes with a faster onset compared to the binding of Ang-II to its classical AT1 receptor. We also found that the complex Ang-II/ACE translocates to the nucleus, through a clathrin-mediated process, triggering a transient nuclear Ca2+ signal. In silico studies revealed a possible interaction site between ACE and phospholipase C (PLC), and experimental results in CHO cells, demonstrated that the β3 isoform of PLC is the one involved in the Ca2+ signals induced by Ang-II/ACE interaction. Further studies in melanoma cells (TM-5) showed that Ang-II induced cell proliferation through ACE activation, an event that could be inhibited either by ACE inhibitor (Lisinopril) or by the silencing of ACE. In addition, we found that stimulation of ACE by Ang-II caused the melanoma cells to migrate, at least in part due to decreased vinculin expression, a focal adhesion structural protein. CONCLUSION: ACE activation regulates melanoma cell proliferation and migration.
No takes yet. Share an insight, caveat, or question.
Alvarenga et al. (2016) studied Melanoma. Angiotensin-II vs. Unstimulated control was evaluated on Cell proliferation (CHO-ACE cells at 15 hours) (p=<0.05). Angiotensin-II induces melanoma cell proliferation and migration through direct binding and activation of the Angiotensin Converting Enzyme, triggering nuclear calcium signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: